Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04303598
What this trial is testing

Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients

Who this might be right for
HIV-infection/Aids
Henan Genuine Biotech Co., Ltd. 720
Not applicableStudy completedNCT01970904
What this trial is testing

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

Who this might be right for
Hepatitis CLiver Disease
Debiopharm International SA 147
Not applicableWithdrawnNCT01692470
What this trial is testing

A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Janssen Pharmaceutica
Testing effectiveness (Phase 2)Study completedNCT00080899
What this trial is testing

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)UnknownNCT05940064
What this trial is testing

Prospective Clinical Study of ZPR Regimen in Elderly Treatment-naive Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Peng Liu 30
Large-scale testing (Phase 3)Study completedNCT01744782
What this trial is testing

Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis

Who this might be right for
Cystinosis
Amgen 17
Not applicableActive Not RecruitingNCT03414151
What this trial is testing

Gut Microbiome in AP Naive

Who this might be right for
Psychotic DisorderSchizophrenia
Centre for Addiction and Mental Health 25
Large-scale testing (Phase 3)Study completedNCT04889430
What this trial is testing

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 34
Not applicableStudy completedNCT06082986
What this trial is testing

A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China

Who this might be right for
Crohn Disease
Xian-Janssen Pharmaceutical Ltd. 200
Early research (Phase 1)UnknownNCT02058680
What this trial is testing

Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients

Who this might be right for
Prostate Cancer
OncBioMune Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT00870870
What this trial is testing

IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 64
Large-scale testing (Phase 3)Study completedNCT01719003
What this trial is testing

Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Hyperglycemia
Boehringer Ingelheim 1,413
Testing effectiveness (Phase 2)Study completedNCT00856375
What this trial is testing

NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer

Who this might be right for
Colorectal Cancer
Nektar Therapeutics 83
Large-scale testing (Phase 3)Active Not RecruitingNCT03391869
What this trial is testing

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung AdenocarcinomaLung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
M.D. Anderson Cancer Center 339
Large-scale testing (Phase 3)Study completedNCT02670772
What this trial is testing

Dose Optimisation of Stavudine for the Treatment of HIV Infection

Who this might be right for
Acquired Immune Deficiency SyndromeHuman Immunodeficiency Virus
Willem Daniel Francois Venter 1,077
Large-scale testing (Phase 3)Study completedNCT05089656
What this trial is testing

Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)

Who this might be right for
Type 2 Spinal Muscular Atrophy
Novartis Pharmaceuticals 126
Not applicableStudy completedNCT03324451
What this trial is testing

The Effectiveness of Intervention on Insulin Injection

Who this might be right for
Type 2 Diabetes Mellitus
Kaohsiung Medical University Chung-Ho Memorial Hospital 151
Large-scale testing (Phase 3)Study completedNCT00369941
What this trial is testing

Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 566
Post-approval studies (Phase 4)WithdrawnNCT00461266
What this trial is testing

ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.

Who this might be right for
HIV Infections
Hoffmann-La Roche
Post-approval studies (Phase 4)Study completedNCT00385957
What this trial is testing

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

Who this might be right for
HIV Infections
Hospital Clinic of Barcelona 70
Next Page